The largest database of trusted experimental protocols

Celltiter 96 cell proliferation assay kit

Manufactured by Promega
Sourced in United States

The CellTiter 96 cell proliferation assay kit is a quantitative colorimetric method used to determine the number of viable cells in proliferation or cytotoxicity assays. It measures the metabolic activity of cells, which is directly proportional to the number of living cells in the culture.

Automatically generated - may contain errors

25 protocols using celltiter 96 cell proliferation assay kit

1

Evaluating Cell Viability with MTS Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For analysis of cell viability, the CellTiter 96-cell proliferation assay kit (MTS, Promega, Madison, WI, USA) was used, according to the manufacturer’s instructions. Briefly, 2 × 104 hBM-MSCs were seeded on 96-well assay plates. After 16 h, the hBM-MSCs were washed with PBS and treated with MNPs@SiO2(RITC) for 12 h. The hBM-MSCs were then washed with PBS to remove excess MNPs@SiO2(RITC), and MTS solution was added to each well (1/10 volume of media). Subsequently, the plate was incubated for 1 h in a 5% CO2 chamber maintained at 37 °C. The absorbance of the soluble formazan was measured using a plate reader (Molecular Devices, San Jose, CA, USA) at 490 nm. Values were normalized relative to the protein absorbance value for each corresponding group.
+ Open protocol
+ Expand
2

Cell Proliferation Assay of Tcam-2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Tcam‐2 cells were plated on 96‐well plates at a density of 5 × 103 per well. We added MTS (CellTiter 96‐cell proliferation assay kit; Promega, Madison, WI, USA) into each well after 0, 1, 2, 3 and 4 days in culture. We read the absorbance at 490 nm to determine the cells’ viability in each well.
+ Open protocol
+ Expand
3

Assessing Nanoparticle Cytotoxicity in Mouse Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effect of nanoparticles on mouse J774 macrophages viability was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) dye reduction assay and the Cell-Titer 96 Cell Proliferation Assay kit (Promega) as described19 (link). Absorbance at 570 nm was measured using a microplate reader.
+ Open protocol
+ Expand
4

Cell Viability Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability assay was performed as described previously [56 (link)]. Cells were seeded on 96-well plates. After indicated stimulation, cell viability was measured by phenazine methosulfate (PMS)/3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) assay using a Cell Titer 96 Cell Proliferation Assay kit (Promega, Madison, USA), according to the manufacturer’s protocol. The absorbance was read at 492 nm using a microplate reader. Data are normalized to control (100%) without stimulus.
+ Open protocol
+ Expand
5

Evaluating Combination Therapies in Prostate Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at 10,000 per well in 96-well culture plates and allowed to grow for 24 hr followed by the desired treatment with increasing concentrations of the indicated agents (Enzalutamide, Abiraterone, GDC-0980, GDC-0941, LY294002 and PF-04691502) for 4 days. Viable cell densities were determined using a CellTiter 96 Cell Proliferation Assay kit (Promega). Absorbance readings at 490 nm were analyzed against the control group for each drug treatment to determine cell viability. The studies were performed in triplicates x 4 and IC50 values were estimated by Calcusyn software (Biosoft, UK). For combination studies of AR inhibition plus PI3K/mTOR inhibition, an equipotent ratio was calculated to determine a combined graded combination treatment. The equipotent ratio is the ratio of the median effects resulting from the single dose treatments of AR inhibitors and PI3K/mTOR inhibitors. A control group was established for each drug treatment in six replicates. The effects of the combined treatments were determined by the combination-index (CI) and isobologram methods derived from the median-effect principle of Chou and Talalay.
+ Open protocol
+ Expand
6

Biocompatibility of Fer and SnF2 in HGK Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vitro biocompatibility of the combination of Fer and SnF2 was investigated in HGK cells using an MTS [(3-(4,5- dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)] assay (CellTiter 96 cell proliferation assay kit; Promega, WI, USA). HGK cells were kindly provided by the laboratory of Dana T. Graves (School of Dental Medicine, University of Pennsylvania) and were cultured in keratinocyte growth medium (Lonza, USA). To determine the cytotoxicity, HGK cells were seeded in 96-well plates at a density of 104 cells per well. Cells were then incubated at 37°C in a humidified 5% CO2 atmosphere in a cell incubator for 24 h. Afterward, old media was replaced with 100 μl of fresh media with or without Fer (1 mg of Fe/ml) and SnF2 (250 ppm of F), or either alone, and incubated for 10 min.
After that, the media was removed, the cells were washed twice with sterile phosphate buffered saline (PBS) and 100 μl of fresh complete cell culture media was added to each well. After 24 h incubation, the cell culture media was removed, and 20 μl of MTS reagent and 100 μl of media were added to each well. After 3 h additional incubation under standard cell culture conditions, the absorbance was recorded at 490 nm using a microplate reader. The cell viability was calculated using the following formula:
Cellviability=A490treatedA490untreated×100%
+ Open protocol
+ Expand
7

Knockdown of Intracellular xCT Levels

Check if the same lab product or an alternative is used in the 5 most similar protocols
The levels of intracellular xCT were knocked down using premade siRNAs of xCT (FlexiTube siRNA, Qiagen, set 1: SI00104895, set 2: SI00104902, set 3: SI00104909, and set 4: SI00104916). Cells at 70–80% confluence were transfected with 0, 2.5, 5, 10, 20 nM of sixCT using Lipofectamine 2000 (InVitrogen, Carlsbad, CA, USA). To ensure the efficacy of sixCT, 10 nM of sixCT was transfected into xCT overexpressing stable clones and cell proliferation was measured at 48 h after the knockdown using CellTiter96 cell proliferation assay kit (Promega, Madison, WI, USA).
+ Open protocol
+ Expand
8

Cell Viability Assay using MTS

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the cell viability assay, an MTS [(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)] assay was performed as described in a previous study [21 (link), 42 , 43 ], using a CellTiter 96-cell proliferation assay kit (Promega Corporation, Madison, WI, USA) according to the manufacturer’s instructions. In this step, 2 × 104 cells were seeded on a 96-well assay plate and treated with MNPs@SiO2(RITC) and SiO2 NPs for 12 h. MTS solution was added to each well of the 96-well assay plate containing treated cells in 100 µL of culture medium. The assay plate was then incubated for 1 h under 5% CO2 at 37 °C. The amount of soluble formazan produced by cellular reduction was directly measured with a plate reader at a wavelength of 490 nm. The values were normalized relative to the protein optical density value for each corresponding group.
+ Open protocol
+ Expand
9

Assessing Cytotoxicity of Docetaxel and Carboplatin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Twenty-four hours prior to the drug treatment, cells (with a density of about 6 × 103 per well) were seeded in the 96-well plate. Docetaxel or carboplatin were used to treat the cells using the indicated dosage for 48 h. We determined cell viability using the CellTiter96® cell proliferation assay kit (Promega, Wisconsin, CA, USA) and followed all manufacturer instructions. GraphPad Prism software was used to calculate the IC50 value of cells treated with and without docetaxel or carboplatin. All experiments were performed in triplicates and repeated thrice.
+ Open protocol
+ Expand
10

In Vitro Biocompatibility of Fer and SnF2

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vitro biocompatibility of the combination of Fer and SnF2 was investigated in HGK cells using an MTS [(3-(4,5- dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)] assay (CellTiter 96 cell proliferation assay kit; Promega, WI, USA). HGK cells were kindly provided by the laboratory of Dana T. Graves (School of Dental Medicine, University of Pennsylvania) and were cultured in KBM-2 medium (Lonza Group AG, Basel, Switzerland). To determine the cytotoxicity, HGK cells were seeded in 96-well plates at a density of 104 cells per well. Cells were then incubated at 37 °C in a humidified 5% CO2 atmosphere in a cell incubator for 24 h. Afterward, old media was replaced with 100 µl of fresh media with or without Fer (1 mg of Fe/ml) and SnF2 (250 ppm of F), or either alone, and incubated for 10 min. After that, the media was removed, the cells were washed twice with sterile phosphate buffered saline (PBS) and 100 µl of fresh complete cell culture media was added to each well. After 24 h incubation, the cell culture media was removed, and 20 µl of MTS reagent and 100 µl of media were added to each well. After 3 h additional incubation under standard cell culture conditions, the absorbance was recorded at 490 nm using a microplate reader. The cell viability was calculated using the following formula: Cellviability=A490treatedA490untreated×100%
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!